Piperacillin - EP

CAS : 66258-76-2

Ref. 3D-FP156813

Informations sur le produit

• Nom: Piperacillin - EP
• Synonymes: Piperacillin hydrate, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, hydrate (1:1), (2S,5R,6R)-, Piperacillin monohydrate, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-, monohydrate, [2S-[2α,5α,6β(S*)]]-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-, monohydrate, (2S,5R,6R)-

Description

Piperacillin - EP is a broad-spectrum antibiotic that belongs to the beta-lactam class of antibiotics. It inhibits bacterial growth by binding to penicillin-binding proteins and prevents them from cross-linking with bacterial cell wall synthesis, which leads to cell lysis. Piperacillin - EP also has an inhibitory effect on the activity of certain enzymes in the bacterial cell wall, such as beta-lactamase, which breaks down the antibiotic. Piperacillin - EP is used for the treatment of complicated infections caused by gram-negative organisms, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Providencia rettgeri and Haemophilus influenzae. The drug can be administered intravenously or intraluminally for systemic infections.
Piperacillin - EP is not active against gram-positive bacteria such as Staphylococ

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 535.57 g/mol
• Formule: C₂₃H₂₉N₅O₈S
• Degré de pureté: Min. 95%